Finanshus indleder dækning af Genmab med et køb
11/7 13:52
Baptista Research on Thursday initiated the coverage of Danish biotechnology company Genmab (GMAB.CO) with an outperform rating and a price target of 1,669.20 Danish kroner....
|
|
|
11/7 13:52
Baptista Research on Thursday initiated the coverage of Danish biotechnology company Genmab (GMAB.CO) with an outperform rating and a price target of 1,669.20 Danish kroner....